跳至主要内容
临床试验/JPRN-UMIN000023590
JPRN-UMIN000023590未知4 期

The Change of focal macular electroretinogram(ERG) in patients with age-related macular degeneration after intravitreal aflibercept(IVA). - Focal macular ERG with wAMD sfter IVA.

Dokkyo Medical University, Koshigaya Hospital Department of Ophthalmology0 个研究点目标入组 50 人开始时间: 2016年8月15日最近更新:
适应症

试验速览

阶段
4 期
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
50years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients with any previous history of treatment of other retinal diseases with pharmacologic agents including verteporfin photodynamic therapy, aflibercept, ranibizumab, bevacizumab or steroids. 2) Clinically significant drug allergy. 3) History of vitrectomy or glaucoma surgery. 4) Presence of RPE tears, angoid streaks or pathologic myopia. 5) Concomitant conditions/diseases including uncontrolled glaucoma and intraocular inflammation 6) Patients who the doctor in charge judges are ineligible for the study

研究者

发起方
Dokkyo Medical University, Koshigaya Hospital Department of Ophthalmology

相似试验

The Change of focal macular electroretinogram(ERG)... | 临床试验